Blood Coagulation & Fibrinolysis

Article	Citations
The role of thrombin in haemostasis	32
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B	20
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case	16
Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis	14
The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis	14
d-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019: a meta-analysis	13
HJHS 2.1 and HEAD-US assessment in the hemophilic joints: How do their findings compare?	13
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	12
Blood biocompatibility enhancement of biomaterials by heparin immobilization: a review	12
The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study	11
Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors	11
Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography	11
Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma	11
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit	10
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU	10
Coronavirus disease 2019 in patients with chronic immune thrombocytopenia on thrombopoietin receptor agonists: new perspectives and old challenges	9
Effects of resveratrol on coagulative, fibrinolytic, and inflammatory marker expression and secretion by endothelial cells (human umbilical vein endothelial cells)	9
Periodontitis, coronary heart disease and myocardial infarction: treat one, benefit all	9
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?	9
High prevalence of overweight/obesity in adult persons with hemophilia in Utah and a review of the literature	8
The physiology of hemostasis	8
Evaluating the potential benefits of the extravascular pool of factor IX	8
ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand	8
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura	8
A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients	8

‘Pulmonary thrombosis in situ’: risk factors, clinic characteristics and long-term evolution	8
Caesalpinia crista coat extract protects red blood cell from sodium nitrite-induced oxidative stress and exhibits antiplatelet activity	8
Evaluation of analytic and clinical performance of thrombin–antithrombin complex and d-dimer assay in prognosis of acute ischemic stroke	8
Postpartum bleeding in women with inherited bleeding disorders: a matched cohort study	7
Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia	7
Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States	7
A comparison of coagulation test results from heparinized central venous catheter and venipuncture	7
Human coagulation factor IX: a systematic review of its characteristics	7
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings	7
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection	7
Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project	7
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism	7
Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls	7
Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia	6
Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients: a practical guide for clinicians	6
Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneum	6
Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coa	6
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: a meta-analysis	6
Current methods of measuring platelet activity: pros and cons	6
Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo	6
Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage	6
Immune thrombocytopenia: options and new perspectives	6
Application of microfluidic chip technology to study the inhibitory effect of tetramethylpyrazine on platelet aggregation, activation, and phosphatidylserine exposure mediated by pathological high she	5
Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma	5
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study	5
Clinical characteristics and outcomes of patients with isolated pulmonary embolism	5
Harmonizing factor assay-related testing performed in a large laboratory network	5
A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal	5
A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism	5
System performance evaluation of the cobas t 711 and cobas t 511 coagulation analyzers in routine laboratory settings	5
Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series	5
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia	5
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice	5
Standard and derived rotational thromboelastometry parameters for prediction of disseminated intravascular coagulation in septic patients	5
Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis	5
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening	5
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review	5
Type II antithrombin deficiency caused by a novel missense mutation (p.Leu417Gln) in a Chinese family	4
Evaluation of 4Ts score inter-rater agreement in patients undergoing evaluation for heparin-induced thrombocytopenia	4
Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children	4
Chronic pain in patients with hemophilia: is it preventable?	4
Interaction of glycated and acetylated human α2-antiplasmin with fibrin clots	4
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?	4
Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia	4
A bispecific antibody demonstrates limited measurability in routine coagulation assays	4
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate	4
A case-report of two patients with hereditary protein S deficiency treated by rivaroxaban	4
Interference of icterus on plasma D-dimer levels measured using immunoturbidimetric assays	4
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets	4
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies	4

Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: a comparison between 3-factor and 4-factor prothrombin complex concentrates	4
Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort	4
Apoptosis in platelets from adult patients with chronic idiopathic thrombocytopenic purpura	3
Thrombosis risk of Alport syndrome patients: evaluation of cardiological, clinical, biochemical, genetic and possible causes of inherited thrombophilia and identification of a novel COL4A3 variant	3
Enzymatic deinduction phenomenon and clinical implications with a focus on direct-acting oral anticoagulants	3
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms	3
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019	3
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	3
Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia	3
Deep intronic F8 c.5999-27A>G variant causes exon 19 skipping and leads to moderate hemophilia A	3
Analysis of phenotype and genotype of a family with hereditary coagulation factor V deficiency caused by the compound heterozygous mutations	3
Homozygous methylentetrahydrofolate reductase C667T genotype anticipates age at venous thromboembolism by one decade	3
General concepts on hemophilia A and on women carrying the disease	3
The impact of atorvastatin on dabigatran plasma levels in patients with atrial fibrillation	3
A challenging case of heparin-induced skin necrosis without thrombocytopenia	3
Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report	3
Microparticles: a link to increased thrombin generation	3
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	3
In-vitro assessment of the effects of fibrinogen, recombinant factor VIIa and factor XIII on trauma-induced coagulopathy	3
Rapamycin induces megakaryocytic differentiation through increasing autophagy in Dami cells	3
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	3
The effect of mycophenolate mofetil on platelet function	3
Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, co	3
Use of thrombolytic agents to treat neonatal thrombosis in clinical practice	3
Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study	3
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial	3
A novel heterozygous mutation (γIIe367Thr) causes congenital dysfibrinogenemia in a Chinese family	3
Use of direct oral anticoagulants in cerebral venous thrombosis: a systematic review	3
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer	3
Gene therapy for hemophilias: the end of phenotypic testing or the start of a new era?	3
Thrombin generation assay: the present and the future	3
Soluble thrombomodulin and cardiovascular disease risk factors in Japanese children	3
Readability and quality assessment of internet-based patient education materials related to deep vein thrombosis	2
Expression and methylation status of vascular endothelial growth factor and thrombospondin-1 genes in congenital factor XIII-deficient patients with intracranial hemorrhage	2
The association between plasminogen activator inhibitor type-1 and clinical outcome in paediatric sepsis	2
Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre	2
Hemophilia carriers: quality of life and management at different life stages	2
Identification of two novel mutations in three children with congenital factor VII deficiency	2
Age, sex and racial differences in fibrin formation and fibrinolysis within the healthy population	2
A novel mutation of SERPINC1 in a patient presenting as recurrent cerebral sinus venous and portal vein thrombosis	2
Postacute elevation of D-dimer levels in severe acute respiratory syndrome coronavirus 2-positive nonhospitalized patients with mild symptoms	2
Prenatal diagnostic techniques and IVF in patients with coagulopathies	2
Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins	2
Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?	2
The association of oxygen saturation, tomography findings and d-dimer levels in coronavirus disease 2019 patients	2
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?	2
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene	2
Risk factors for recurrent venous thromboembolism: a real-world analysis	2
Cranberry supplementation as a cause of major intraoperative bleeding during vascular surgery due to aspirin-like platelet inhibition	2
Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility	2
Screening hemostatic defects in Saudi University students with unexplained menorrhagia: a diagnosis, which could be missed	2
Spinal epidural hematoma in a child with hemophilia A with high titer inhibitors and follow-up with prophylactic emicizumab: case report and literature review	2
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience	2
Reduced IL-35 in patients with immune thrombocytopenia	2
Outpatient central venous access device insertion in very young children with severe haemophilia	2
Evaluation of ISTH-BAT as a predictor for factor deficiency in haemophilia carriers: a single-centre experience	2
Use of recombinant activated factor VII for uncontrolled bleeding in a haematology/oncology paediatric ICU cohort	2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event	2
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period	2
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran	2
Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey	2
Relationship between oxidant-antioxidant status and hypercoagulobility indices in children with iron deficiency anaemia	2
New developments in the diagnosis of primary immune thrombocytopenia	2
Thrombohaemorhhagic balance in coronavirus disease 2019 and its management: a perspective	2
The effect of tranexamic acid on myocardial injury in cardiac surgical patients: a systematic review and meta-analysis	2
Analytical performance evaluation of Sysmex CS-2500 and Stago STA Compact	2
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	2
A multicentre real-world data study to assess the bleeding rate and management of patients with haemophilia A and factor VIII inhibitors in Argentina	2
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency	2
Foundations of hemophilia and epidemiology	2
Successful treatment of a massive sinus thrombosis in a Chinese woman with antithrombin III deficiency: a case report and review of the literature	2
Psychological complications among patients with congenital bleeding disorders	2
Which tests can most effectively indicate the clinical phenotype of paediatric haemophilia patients with prophylaxis?	2
Leukocyte-platelet rich fibrin on the treatment of a large paradental cyst: a novel regenerative approach	2
Cangrelor for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia: it is not so easy	2
Effects of rivaroxaban and dabigatran on global hemostasis in patients with atrial fibrillation	2
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays	2
Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study	2
Venous thromboembolism and acute myeloid leukemia: risk factors and mortality in elderly white, black and Asian patients	2
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier	2

Microkinetic coagulation assays for human and zebrafish plasma	2
Prolonged activated partial thromboplastin time with no clear explanation	2
Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection	1
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia	1
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury	1
Discrepancy between the results of one-stage and chromogenic factor VIII:C assays in patients with mild/moderate hemophilia A	1
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography	1
The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection	1
Hereditary factor V deficiency from heterozygous mutations with a novel variant p.Pro798Leufs∗13 in the F5 gene	1
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study	1
2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making	1
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients	1
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada	1
Clinical phenotype and F7 gene genotype in 40 Tunisian patients with congenital factor VII deficiency	1
Evaluation of the algorithm of Anticlot Assistant: an anticoagulant management system based on mobile health technology	1
Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation	1
A novel mutation (Ser951LeufsTer8) in F5 gene leads to hereditary coagulation factor V deficiency	1
Preservation of thrombin generation in cirrhosis despite abnormal results of international normalized ratio: implications for invasive procedures	1
Transplacental hemophilia A and prophylactic treatment with intravenous immunoglobulin and recombinant factor VIIa in the newborn period: a case report	1
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics	1
State of the art of genetic studies in hemophilia carriers	1
Familial macro thrombocytopenia: role of genetics where morphology fails	1
The value of brain natriuretic peptide in the prosthetic valve thrombosis	1
Whole blood viscosity in patients with aortic stenosis	1
Seasonal and meteorological associations of vitamin K-dependent coagulation factors in 1-month-old infants: assessment of Normotest values	1
Hemostatic cover in orthopedic surgery	1
Coagulopathy following Crotaliπae snakebites in northeast Florida	1
Severe thrombocytopenia in pregnancy: a retrospective study	1
Thromboelastometry-guided neuraxial anesthesia in a parturient with severe thrombocytopenia due to large granular lymphocytic leukemia	1
Isovolemic filter-based therapeutic plasma-exchange with fresh frozen plasma is associated with minimal thromboelastometric changes in noncoagulopathic patients	1
Kaolin, used to trigger coagulation in thrombin generation test, increases sensitivity of the method in hemophilia patients	1
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment	1
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients	1
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency	1
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	1
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	1
New treatments for primary immune thrombocytopenia	1
Synthesis and antithrombotic activity of 1-benzyl-N′-benzylidenepiperidine-3-carbohydrazide derivatives	1
Lidocaine effects on coagulation assessed by whole blood rotational thromboelastometry	1
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations	1
Effect of emergency department fibrinogen testing on survival of trauma patients receiving blood transfusions	1
Polymorphism rs2762939 of CYP24A1 enzyme and coronary artery disease: angiographic results from a large prospective cohort of patients	1
Physician practices in evaluation and treatment of patients with generalized joint hypermobility and bleeding	1
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes	1
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience	1
A novel splicing mutation in F8 causes various aberrant transcripts in a hemophilia A patient and identifies a new transcript from healthy individuals	1
Obesity and physical exercise in hemophilia	1
Evaluation of primary care physicians’ approaches to hemophilia and bleeding disorders: a questionnaire survey	1
The effects of lung involvement, clinical and laboratory parameters on outcome in elderly patients with coronavirus disease 2019	1
Peripartum management of deep venous thrombosis in the context of antithrombin deficiency and May–Thurner syndrome	1
Hemophilia A and von Willebrand deficiency: therapeutic implications	1
Tranexamic acid is effective in decreasing postoperative intraarticular bleeding in arthroscopic knee surgery	1
A novel missense mutation in F9 gene causes hemophilia B in a family with clinical variability	1
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients	1
The utility and complications of plasma administration in cirrhotic patients undergoing minimally invasive procedures	1
The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A	1
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage	1
Endothelium-biomarkers for postthrombotic syndrome: a case–control study	1
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding	1
Cost-effectiveness of thrombotic thrombocytopenic purpura diagnosis: a retrospective analysis in the University Hospital Center of Lyon (France)	1
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe	1
Once-weekly prophylaxis regimen of nonacog alfa in patients with hemophilia B: an analysis of timing of bleeding event onset	1
Identification of a novel mutation in congenital afibrinogenemia in Iranian patients	1
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing	1
Fibrinolytic drugs induced hemorrhage: mechanisms and solutions	1
Platelets parameters in septic shock: clinical usefulness and prognostic value	1
An exceptional case of severe combined inherited thrombophilia successfully treated with rivaroxaban	1
Acquired haemophilia A and late development of secondary autoimmune disorders, evidences from a single-centre observational study	1
Refractory acquired haemophilia A in a patient with HIV treated with Emicizumab	1
P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia	1
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system	1
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study	1